In humans, G-CSF is used to induce HSPC mobilization in severe chronic neutropenic disease, to reduce chemotherapy-induced neutropenia as well as in healthy donors for allogenic hematopoietic cell transplantation for neutropenic patients [35,36]. This evidence concerns the gene CSF3 and Decreased total neutrophil count.